Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
Home
About UsRefund & CancellationProduct / Service Details
Contact UsDelivery & Shipping PolicyPrivacy Policy
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine

Besponsa 1mg Injection

vial of 1.0 Injection
Prescription Required
30 minute delivery
vial of 1.0 Injection
₹ 330000.00
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Salt Composition

Inotuzumab Ozogamacin (1mg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Salt Composition

Inotuzumab Ozogamacin (1mg)

Key Information

Short Description

Besponsa 1mg Injection is a CD22-directed antibody-drug conjugate (ADC) used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Dosage Form

Injection

Introduction

Besponsa 1mg Injection is given as an injection into veins by the healthcare provider. The dose will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or in more than the recommended dose can cause very serious side effects. It may take several weeks or months to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Directions for Use

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Safety Information

Side Effects

Decreased blood cells (red cells, white cells, and platelets) Infection Fatigue Hemorrhage Fever Nausea Headache Increased liver enzymes Abdominal pain

Breastfeeding Warning

Breastfeeding Warning

Avoid breastfeeding during the treatment and for two months after the last dose.

How it works

Besponsa 1mg Injection contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. It targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells.

Quick Tips

Your doctor may monitor your blood counts and liver before you start taking Besponsa 1mg Injection and regularly throughout your treatment. Males and females of reproductive potential should use effective contraception during the treatment and for at least five and eight months respectively after the last dose. Avoid breastfeeding during the treatment and for two months after the last dose. Besponsa 1mg Injection can make you feel dizzy for the first few days. Rise slowly if you have been sitting or lying down for a long time. After starting the treatment with Besponsa 1mg Injection, you may be at risk of infection; so try to avoid crowds or people with colds and report fever or any other signs of infection immediately to your doctor.

Short Description

Besponsa 1mg Injection is a CD22-directed antibody-drug conjugate (ADC) used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Dosage Form

Injection

Introduction

Besponsa 1mg Injection is given as an injection into veins by the healthcare provider. The dose will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or in more than the recommended dose can cause very serious side effects. It may take several weeks or months to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Side Effects

Decreased blood cells (red cells, white cells, and platelets) Infection Fatigue Hemorrhage Fever Nausea Headache Increased liver enzymes Abdominal pain
Breastfeeding Warning

Breastfeeding Warning

Avoid breastfeeding during the treatment and for two months after the last dose.
Besponsa 1mg Injection contains Inotuzumab Ozogamicin, an antineoplastic agent that treats relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL) in adults. It targets CD22 antigen expressed on immature B-cell lymphocytes and blocks further growth of tumor cells.
Your doctor may monitor your blood counts and liver before you start taking Besponsa 1mg Injection and regularly throughout your treatment. Males and females of reproductive potential should use effective contraception during the treatment and for at least five and eight months respectively after the last dose. Avoid breastfeeding during the treatment and for two months after the last dose. Besponsa 1mg Injection can make you feel dizzy for the first few days. Rise slowly if you have been sitting or lying down for a long time. After starting the treatment with Besponsa 1mg Injection, you may be at risk of infection; so try to avoid crowds or people with colds and report fever or any other signs of infection immediately to your doctor.

Related Medicines

medicine

Inonza 1mg Injection

vial of 1.0 Injection
20% offvial of 1.0 Injection
₹ 330000.00
20% off
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries